Sarah leads strategic development, communication and investor liaison activities at SENISCA. With over 20 years’ experience in the biopharmaceutical sector, Sarah was a senior research leader prior to developing a successful career in life sciences investment. Sarah is a recognised leader in strategic development, pipeline creation and critical evaluation of business development opportunities, with a focus on the development of early phase biotech. Sarah holds a PhD from the University of Cambridge.